The paradigm of IL-6: from basic science to medicine.Tetsuji Naka, Tadamitsu Kishimoto|Arthritis Research|2002Cited by 481
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitisSatoshi Serada, Tetsuji Naka|Inflammatory Bowel Diseases|2012Cited by 230
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinomaHisashi Hara, Tetsuji Naka|British Journal of Cancer|2016Cited by 135
SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver DiseasesMinoru Fujimoto, Tetsuji Naka|Gastroenterology Research and Practice|2010Cited by 118
Anti‐glypican‐1 antibody‐drug conjugate exhibits potent preclinical antitumor activity against glypican‐1 positive uterine cervical cancerSatoko Matsuzaki, Tetsuji Naka|International Journal of Cancer|2017Cited by 66